Aviance Capital Partners LLC Invests $612,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Aviance Capital Partners LLC purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 1st quarter, HoldingsChannel reports. The institutional investor purchased 1,533 shares of the medical equipment provider’s stock, valued at approximately $612,000.

Several other large investors have also recently made changes to their positions in the stock. Baystate Wealth Management LLC increased its holdings in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 45 shares during the period. MCF Advisors LLC increased its holdings in shares of Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 40 shares during the period. Able Wealth Management LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at about $28,000. Atticus Wealth Management LLC increased its holdings in shares of Intuitive Surgical by 85.4% in the fourth quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 41 shares during the period. Finally, MeadowBrook Investment Advisors LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at about $30,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Down 0.1 %

Shares of Intuitive Surgical stock traded down $0.46 during mid-day trading on Monday, reaching $444.39. 169,889 shares of the stock traded hands, compared to its average volume of 1,516,214. The business has a 50-day moving average of $403.83 and a 200 day moving average of $383.50. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $448.10. The stock has a market capitalization of $157.63 billion, a PE ratio of 80.30, a PEG ratio of 5.75 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter in the prior year, the firm earned $1.00 earnings per share. The business’s revenue was up 11.5% compared to the same quarter last year. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Jefferies Financial Group increased their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a report on Friday, April 19th. Stifel Nicolaus upped their target price on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, April 8th. BTIG Research upped their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Piper Sandler upped their target price on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research note on Friday, April 19th. Finally, Robert W. Baird lowered their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday, April 19th. Five research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $403.67.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 1,498 shares of the stock in a transaction that occurred on Friday, April 26th. The stock was sold at an average price of $369.92, for a total value of $554,140.16. Following the completion of the sale, the executive vice president now owns 5,507 shares of the company’s stock, valued at $2,037,149.44. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 1,498 shares of the firm’s stock in a transaction on Friday, April 26th. The stock was sold at an average price of $369.92, for a total transaction of $554,140.16. Following the completion of the sale, the executive vice president now owns 5,507 shares of the company’s stock, valued at $2,037,149.44. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the sale, the director now directly owns 25,319 shares of the company’s stock, valued at approximately $9,385,753.30. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,956 shares of company stock valued at $6,927,011. 0.80% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.